News – Page 530 – Endpoints News

What drug categories spend the most on advertising? Diabetes, psoriasis and arthritis top the list

4 years ago

Fujifilm continues its biotech building spree with new facility in China

4 years ago

French president names Stéphane Bancel a Chevalier for Moderna's Covid triumph

4 years ago

A new spinout wades into ovarian aging, armed with a seed round and experimental drugs from Mass General

4 years ago

Ahead of FDA, EMA recommends authorizing new gene therapy treatment for ultra-rare disease

4 years ago

Athersys tries to post-hoc-analyze its way out of another trial fail for stroke stem cell therapy

4 years ago

Scoop: After pulling IPO ambitions last December, Jeff Aronin's Castle Creek turns to private backers

4 years ago

Trying to shake up the Parkinson's paradigm, AbbVie submits NDA for continuous, 24-hour infusion therapy

4 years ago

All Blue's $733M bid to acquire Zymeworks turns hostile as board battles back — after a biotech celebrity jumps in

4 years ago

Sanofi's $20B buyout of Genzyme pays off again with European OK for first Niemann-Pick drug

4 years ago

Touting 100% OS rate in pivotal rare disease trial, Rocket Pharma ready to head to FDA

4 years ago

Flagship's Foghorn, partnered with Merck and Eli Lilly, gets a partial FDA hold after patient death

4 years ago

Ex-Takeda exec hits the ground running at the helm of rare disease biotech — with 3 priorities off the bat; ...

4 years ago

Bayer sounds retreat from a $670 million CAR-T pact in the wake of a patient death

4 years ago

Gilead leads HIV grantmakers list, tops Gates Foundation in a first for annual survey

4 years ago

Pfizer delves into diversity-focused clinical trial partnership

4 years ago

Proactively preventing shortages: New FDA guidance spells out which drugs require risk management plans

4 years ago

Moderna chairman Noubar Afeyan defends vetting process in wake of CFO scandal — report

4 years ago

Roche and bluebird bio settle year-long trademark case, but keep quiet on the details

4 years ago

Maryland offers loan to Clene despite ALS trial bumps

4 years ago

SQZ's outside-the-box manufacturing method slashes production time early in study

4 years ago

Catalent introduces new AAV gene therapy tech in aim to speed up manufacturing process

4 years ago

With new acquisition, Bora to venture into biologics

4 years ago

A year after scoring FDA approval for diabetes drug, Zealand touts positive PhIII data for new indication

4 years ago

First page Previous page 527 528 529530531 532 533 Next page Last page